Synapse - John Vito K Deluca

John Vito K Deluca

Research Focus

Former Employee. Medicine; Sr. Research Proj Coordinator

Recent additions – View all

A phase Ib study of BEZ235, a dual inhibitor of phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR), in patients with advanced renal cell carcinoma
Journal Article

Carlo, M. I.; Molina, A. M.; Lakhman, Y.; Patil, S.; Woo, K.; Deluca, J.; Lee, C. H.; Hsieh, J. J.; Feldman, D. R.; Motzer, R. J.; more...
The Oncologist (2016)

Fulltext@MSK | Save
Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients: Implications for clinical trial design and interpretation
Journal Article

Patil, S.; Ishill, N.; Deluca, J.; Motzer, R. J.
Cancer (2010)

Fulltext@MSK | Save
Trends in Memorial Sloan-Kettering Cancer Center risk group distribution according to treatment year for patients with metastatic renal cell carcinoma (mRCC)
Meeting Abstract

Patil, S.; Ishill, N. M.; Deluca, J.; Motzer, R. J.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Co-authors at MSK

8

Motzer
7

Leoce
4

Bacik
4

Kondagunta
4

Patil
4

Schwartz
2

Feldman
2

Gornell
2

Russo
1

Bains
1

Bajorin
1

Bosl
1

Budnick
1

Carlo
1

Chaganti
1

Hsieh
1

Korkola
1

Lakhman
1

Lee
1

Mazumdar
1

Patel
1

Reich
1

Reuter
1

Ronnen
1

Sheinfeld
1

Voss
1

Woo

Types of Work

Publications